| Financial Year |
March 31 2023 |
| Monetary Funds |
1,431,905,048.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,662,075.00 |
| Accounts Receivable |
538,872,423.46 |
| Advances to Suppliers |
218,774,239.57 |
| Other Receivables |
62,035,752.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,057,573,021.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
55,998.46 |
| Total Current Assets |
4,310,878,558.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,776,954,949.14 |
| Under-construction Projects |
667,688,909.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
222,585,251.85 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
147,929,361.73 |
| R&D expenses |
-- |
| Goodwill |
26,871,974.18 |
| Long-Term Deferred and Prepaid Expenses |
10,599,477.20 |
| Deferred Income Tax Assets |
68,376,219.82 |
| Other Non-Current Assets |
559,485,954.21 |
| Sub-Total of Non-Current Assets |
3,557,601,132.50 |
| Total Assets |
7,868,479,691.15 |
| Short-Term Loans |
1,423,730,967.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
608,210,000.00 |
| Accounts Payable |
496,994,318.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,885,335.39 |
| Taxes Payable |
9,396,517.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
228,632,648.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
146,090,485.60 |
| Other Current Liabilities |
21,360,907.10 |
| Sub-Total of Current Liabilities |
3,182,120,795.08 |
| Long-term Loans |
196,000,000.00 |
| Bonds Payable |
872,485,856.15 |
| Long-Term Accounts Payable |
13,970,301.79 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,126,238.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,188,120,402.62 |
| Total Liabilities |
4,370,241,197.70 |
| Paid-In Capital(Or Share Stock) |
1,079,159,360.00 |
| Capital Surplus |
832,015,059.48 |
| Surplus Reserve |
263,717,929.16 |
| LESS:Treasury Stock |
79,697,673.01 |
| Undistributed Profits |
1,044,170,091.36 |
| Minority Stockholder's Interest |
199,079,866.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,299,158,626.59 |
| Owner's Equity（Stockholder's Equity） |
3,498,238,493.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,868,479,691.15 |
